[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Next Generation Sequencing-Global Market Status and Trend Report 2013-2023

May 2018 | 153 pages | ID: N6B9736AC268EN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Next Generation Sequencing-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Next Generation Sequencing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Next Generation Sequencing 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Next Generation Sequencing worldwide, with company and product introduction, position in the Next Generation Sequencing market
Market status and development trend of Next Generation Sequencing by types and applications
Cost and profit status of Next Generation Sequencing, and marketing status
Market growth drivers and challenges

The report segments the global Next Generation Sequencing market as:

Global Next Generation Sequencing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Next Generation Sequencing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
454-Sequencing
Illumina Sequencing
Others

Global Next Generation Sequencing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Hereditary Disease Detection
Life Science

Global Next Generation Sequencing Market: Manufacturers Segment Analysis (Company and Product introduction, Next Generation Sequencing Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific
Illumina
Roche Sequencing
Pacific Biosciences
BGI
Novo gene
Biomarker
Roche
Daan Gene
Berry Genomics

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEXT GENERATION SEQUENCING

1.1 Definition of Next Generation Sequencing in This Report
1.2 Commercial Types of Next Generation Sequencing
  1.2.1 454-Sequencing
  1.2.2 Illumina Sequencing
  1.2.3 Others
1.3 Downstream Application of Next Generation Sequencing
  1.3.1 Oncology
  1.3.2 Hereditary Disease Detection
  1.3.3 Life Science
1.4 Development History of Next Generation Sequencing
1.5 Market Status and Trend of Next Generation Sequencing 2013-2023
  1.5.1 Global Next Generation Sequencing Market Status and Trend 2013-2023
  1.5.2 Regional Next Generation Sequencing Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Next Generation Sequencing 2013-2017
2.2 Sales Market of Next Generation Sequencing by Regions
  2.2.1 Sales Volume of Next Generation Sequencing by Regions
  2.2.2 Sales Value of Next Generation Sequencing by Regions
2.3 Production Market of Next Generation Sequencing by Regions
2.4 Global Market Forecast of Next Generation Sequencing 2018-2023
  2.4.1 Global Market Forecast of Next Generation Sequencing 2018-2023
  2.4.2 Market Forecast of Next Generation Sequencing by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Next Generation Sequencing by Types
3.2 Sales Value of Next Generation Sequencing by Types
3.3 Market Forecast of Next Generation Sequencing by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Next Generation Sequencing by Downstream Industry
4.2 Global Market Forecast of Next Generation Sequencing by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Next Generation Sequencing Market Status by Countries
  5.1.1 North America Next Generation Sequencing Sales by Countries (2013-2017)
  5.1.2 North America Next Generation Sequencing Revenue by Countries (2013-2017)
  5.1.3 United States Next Generation Sequencing Market Status (2013-2017)
  5.1.4 Canada Next Generation Sequencing Market Status (2013-2017)
  5.1.5 Mexico Next Generation Sequencing Market Status (2013-2017)
5.2 North America Next Generation Sequencing Market Status by Manufacturers
5.3 North America Next Generation Sequencing Market Status by Type (2013-2017)
  5.3.1 North America Next Generation Sequencing Sales by Type (2013-2017)
  5.3.2 North America Next Generation Sequencing Revenue by Type (2013-2017)
5.4 North America Next Generation Sequencing Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Next Generation Sequencing Market Status by Countries
  6.1.1 Europe Next Generation Sequencing Sales by Countries (2013-2017)
  6.1.2 Europe Next Generation Sequencing Revenue by Countries (2013-2017)
  6.1.3 Germany Next Generation Sequencing Market Status (2013-2017)
  6.1.4 UK Next Generation Sequencing Market Status (2013-2017)
  6.1.5 France Next Generation Sequencing Market Status (2013-2017)
  6.1.6 Italy Next Generation Sequencing Market Status (2013-2017)
  6.1.7 Russia Next Generation Sequencing Market Status (2013-2017)
  6.1.8 Spain Next Generation Sequencing Market Status (2013-2017)
  6.1.9 Benelux Next Generation Sequencing Market Status (2013-2017)
6.2 Europe Next Generation Sequencing Market Status by Manufacturers
6.3 Europe Next Generation Sequencing Market Status by Type (2013-2017)
  6.3.1 Europe Next Generation Sequencing Sales by Type (2013-2017)
  6.3.2 Europe Next Generation Sequencing Revenue by Type (2013-2017)
6.4 Europe Next Generation Sequencing Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Next Generation Sequencing Market Status by Countries
  7.1.1 Asia Pacific Next Generation Sequencing Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Next Generation Sequencing Revenue by Countries (2013-2017)
  7.1.3 China Next Generation Sequencing Market Status (2013-2017)
  7.1.4 Japan Next Generation Sequencing Market Status (2013-2017)
  7.1.5 India Next Generation Sequencing Market Status (2013-2017)
  7.1.6 Southeast Asia Next Generation Sequencing Market Status (2013-2017)
  7.1.7 Australia Next Generation Sequencing Market Status (2013-2017)
7.2 Asia Pacific Next Generation Sequencing Market Status by Manufacturers
7.3 Asia Pacific Next Generation Sequencing Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Next Generation Sequencing Sales by Type (2013-2017)
  7.3.2 Asia Pacific Next Generation Sequencing Revenue by Type (2013-2017)
7.4 Asia Pacific Next Generation Sequencing Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Next Generation Sequencing Market Status by Countries
  8.1.1 Latin America Next Generation Sequencing Sales by Countries (2013-2017)
  8.1.2 Latin America Next Generation Sequencing Revenue by Countries (2013-2017)
  8.1.3 Brazil Next Generation Sequencing Market Status (2013-2017)
  8.1.4 Argentina Next Generation Sequencing Market Status (2013-2017)
  8.1.5 Colombia Next Generation Sequencing Market Status (2013-2017)
8.2 Latin America Next Generation Sequencing Market Status by Manufacturers
8.3 Latin America Next Generation Sequencing Market Status by Type (2013-2017)
  8.3.1 Latin America Next Generation Sequencing Sales by Type (2013-2017)
  8.3.2 Latin America Next Generation Sequencing Revenue by Type (2013-2017)
8.4 Latin America Next Generation Sequencing Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Next Generation Sequencing Market Status by Countries
  9.1.1 Middle East and Africa Next Generation Sequencing Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Next Generation Sequencing Revenue by Countries (2013-2017)
  9.1.3 Middle East Next Generation Sequencing Market Status (2013-2017)
  9.1.4 Africa Next Generation Sequencing Market Status (2013-2017)
9.2 Middle East and Africa Next Generation Sequencing Market Status by Manufacturers
9.3 Middle East and Africa Next Generation Sequencing Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Next Generation Sequencing Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Next Generation Sequencing Revenue by Type (2013-2017)
9.4 Middle East and Africa Next Generation Sequencing Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCING

10.1 Global Economy Situation and Trend Overview
10.2 Next Generation Sequencing Downstream Industry Situation and Trend Overview

CHAPTER 11 NEXT GENERATION SEQUENCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Next Generation Sequencing by Major Manufacturers
11.2 Production Value of Next Generation Sequencing by Major Manufacturers
11.3 Basic Information of Next Generation Sequencing by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Next Generation Sequencing Major Manufacturer
  11.3.2 Employees and Revenue Level of Next Generation Sequencing Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 NEXT GENERATION SEQUENCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Thermo Fisher Scientific
  12.1.1 Company profile
  12.1.2 Representative Next Generation Sequencing Product
  12.1.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
12.2 Illumina
  12.2.1 Company profile
  12.2.2 Representative Next Generation Sequencing Product
  12.2.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Illumina
12.3 Roche Sequencing
  12.3.1 Company profile
  12.3.2 Representative Next Generation Sequencing Product
  12.3.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche Sequencing
12.4 Pacific Biosciences
  12.4.1 Company profile
  12.4.2 Representative Next Generation Sequencing Product
  12.4.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Pacific Biosciences
12.5 BGI
  12.5.1 Company profile
  12.5.2 Representative Next Generation Sequencing Product
  12.5.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of BGI
12.6 Novo gene
  12.6.1 Company profile
  12.6.2 Representative Next Generation Sequencing Product
  12.6.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Novo gene
12.7 Biomarker
  12.7.1 Company profile
  12.7.2 Representative Next Generation Sequencing Product
  12.7.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Biomarker
12.8 Roche
  12.8.1 Company profile
  12.8.2 Representative Next Generation Sequencing Product
  12.8.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche
12.9 Daan Gene
  12.9.1 Company profile
  12.9.2 Representative Next Generation Sequencing Product
  12.9.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Daan Gene
12.10 Berry Genomics
  12.10.1 Company profile
  12.10.2 Representative Next Generation Sequencing Product
  12.10.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Berry Genomics

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCING

13.1 Industry Chain of Next Generation Sequencing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCING

14.1 Cost Structure Analysis of Next Generation Sequencing
14.2 Raw Materials Cost Analysis of Next Generation Sequencing
14.3 Labor Cost Analysis of Next Generation Sequencing
14.4 Manufacturing Expenses Analysis of Next Generation Sequencing

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications